GnRH effects on placental hormones during gestation. III. Prostaglandin E, prostaglandin F, and 13,14-dihydro-15-keto-prostaglandin F.

We studied the release of prostaglandin E (PGE), prostaglandin F (PGF) and 13,14-dihydro-15-keto-prostaglandin F (MPF) from explants of human placentas of different gestational ages and the effect of gonadotropin-releasing hormone (GnRH) on this release. The greatest basal release of PGE, PGF and MPF was in the cultures from 9- to 13-wk placentas, with the release on the second and third days of culture increasing 4- to 10-fold from that of the first day. In cultures from 15-wk to term placentas, the initial basal release (Day 1) of these prostaglandins was only slightly higher than in cultures from 6-wk placentas. In cultures from term placentas, the later increase with extended culture was absent or very small. Addition of synthetic GnRH to the cultures from 6- to 9-wk placentas effected no significant change in release of PGE, PGF or MPF. However, GnRH added to the cultures from 13-wk placentas effected a dose-related inhibition of these prostaglandins. After 15 wk, we observed a stimulation of these prostaglandins by GnRH that was as much as 50-fold; stimulation was highly significant in the cultures from 16- and 17-wk, as well as in those from the term placentas. These data demonstrate an action of GnRH on prostaglandin release and indicate that both the basal release of PGE, PGF and MPF and the response to GnRH are related to the gestational age of the placenta.

[1]  T. Siler-Khodr,et al.  Gonadotropin-releasing hormone effects on placental hormones during gestation: II. Progesterone, estrone, estradiol and estriol. , 1986, Biology of reproduction.

[2]  J. Lehoux,et al.  Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin. , 1984, The Journal of clinical endocrinology and metabolism.

[3]  J. Challis,et al.  Prostaglandin output in relation to parturition by cells dispersed from human intrauterine tissues. , 1983, The Journal of clinical endocrinology and metabolism.

[4]  M. Harper,et al.  Prostaglandin production by human term placentas in vitro. , 1983, Prostaglandins, leukotrienes, and medicine.

[5]  R. Haning,et al.  Effects of prostaglandins, dibutyryl cAMP, LHRH, estrogens, progesterone, and potassium on output of prostaglandin F2 alpha, 13, 14-dihydro-15-keto-prostaglandin F2 alpha, hCG, estradiol, and progesterone by placental minces. , 1982, Prostaglandins.

[6]  T. Maeda,et al.  Changes in Luteinizing Hormone-Releasing Hormone in Human Placenta Throughout Pregnancy , 1982, Obstetrics and gynecology.

[7]  R. Haning,et al.  Effects of dibuturyl cAMP, LHRH, and aromatase inhibitor on simultaneous outputs of prostaglandin F2α, and 13,14-dihydro-15-keto-prostaglandin F2α by term placental explants , 1982 .

[8]  R. Sharpe,et al.  Human placental receptors for luteinizing hormone releasing hormone. , 1981, Biochemical and biophysical research communications.

[9]  T. Siler-Khodr,et al.  Extrahypothalamic luteinizing hormone-releasing factor (LRF): release of immunoreactive LRF in vitro. , 1979, Fertility and sterility.

[10]  T. Siler-Khodr,et al.  Content of luteinizing hormone-releasing factor in the human placenta. , 1978, American journal of obstetrics and gynecology.

[11]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.